Moloney Securities Asset Management’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-23,500
Closed -$78K 520
2025
Q1
$78K Sell
23,500
-24,000
-51% -$84.3K 0.01% 460
2024
Q4
$146K Sell
47,500
-34,000
-42% -$116K 0.02% 431
2024
Q3
$297K Sell
81,500
-83,500
-51% -$339K 0.04% 359
2024
Q2
$756K Sell
165,000
-13,000
-7% -$63.4K 0.11% 210
2024
Q1
$878K Buy
178,000
+93,800
+111% +$453K 0.13% 188
2023
Q4
$397K Buy
84,200
+59,700
+244% +$223K 0.06% 289
2023
Q3
$62.4K Hold
24,500
0.01% 407
2023
Q2
$110K Sell
24,500
-4,000
-14% -$18.1K 0.02% 392
2023
Q1
$142K Sell
28,500
-25,450
-47% -$82.4K 0.03% 387
2022
Q4
$111K Buy
53,950
+32,500
+152% +$73K 0.02% 372
2022
Q3
$56K Sell
21,450
-17,000
-44% -$59.6K 0.01% 359
2022
Q2
$139K Sell
38,450
-33,000
-46% -$167K 0.03% 345
2022
Q1
$552K Buy
71,450
+30,800
+76% +$346K 0.11% 212
2021
Q4
$573K Buy
40,650
+11,400
+39% +$168K 0.1% 223
2021
Q3
$513K Buy
+29,250
New +$514K 0.09% 237

Other funds holding SOPH

Moloney Securities Asset Management's SOPH Position: Q2 2025 in Review

Moloney Securities Asset Management sold out of SOPHiA GENETICS (SOPH) in Q2 2025, closing a stake of 23,500 shares — an estimated $78K sold.

Moloney Securities Asset Management first reported a position in SOPH in Q3 2021 and held it in 15 quarters. The position peaked at $878K in Q1 2024. 32 funds tracked by Wall St. Rank hold SOPH as of Q2 2025.

  • Moloney Securities Asset Management reported no remaining SOPHiA GENETICS position as of Q2 2025 after selling out during the quarter.
  • Moloney Securities Asset Management sold 23,500 SOPHiA GENETICS shares in Q2 2025, an estimated $78K.
  • Moloney Securities Asset Management first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 15 quarters.
  • Moloney Securities Asset Management's SOPHiA GENETICS position peaked at $878K in Q1 2024.
  • 32 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2025.

Based on Moloney Securities Asset Management's 13F filing for Q2 2025, filed 31 Jul 2025.